FDA OKs First IL-15 Receptor Agonist for Early Bladder Cancer Novel immunotherapy induced complete responses in 62% of patients with BCG-unresponsive NMIBC Apr 23, 2024
Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests News, features, and commentary about cancer-related issues Apr 19, 2024
California Sets Long-Awaited Drinking Water Limit for 'Erin Brockovich' Contaminant The rule is the first in the nation to specifically target the heavy metal Apr 18, 2024
FDA Slaps Embolization Device With Class I Recall After Deaths Increased bowel ischemia risk when Obsidio Embolic is used for lower GI bleeds Apr 17, 2024
Immunotherapy During Pregnancy Just as Safe as Other Cancer Drugs However, use should be avoided "if possible" due to risk of rare immune-related adverse events Apr 17, 2024
Roundup Maker Seeks Lawmakers' Help to Squelch Claims It Failed to Warn About Cancer Legal experts say legislation could provide immunity from lawsuits Apr 16, 2024
What Kate Middleton Reminds Us About the Role of Privacy in Healing Everyone deserves the "sanctity of space" during a course of illness Apr 15, 2024
Journey Into Virtual Reality Eases Cancer Pain VR distraction therapy could be a useful non-pharmacologic alternative, study suggests Apr 12, 2024
'I'm Dying, You're Not': Terminally Ill Ask More States for Physician-Assisted Death Debates on medical aid in dying bills are playing out in Kentucky, Delaware, Maryland, and Iowa Apr 12, 2024
Riding the 'Boob Bus'; Prior Authorization Pushback; Cancer Warning for Alcohol? News, features, and commentary about cancer-related issues Apr 12, 2024
1,000 Paper Cranes Can Bring Our Patients One Step Closer to Healing We must remind our patients to hold on to hope Apr 11, 2024
O.J. Simpson Dies After Cancer Battle Football star who was acquitted of murders but later found liable in civil trial dead at 76 Apr 11, 2024
Neoadjuvant Chemo-IO Promising in Borderline Resectable Pancreatic Cancer Combination associated with favorable R0 resection and survival rates Apr 10, 2024
Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists Study findings support conclusions of the European Medicines Agency's recent investigation Apr 10, 2024
Bispecific Checkpoint Inhibitor Improves Survival in Advanced Gastric/GEJ Cancer Almost 50% improvement in median survival, but against a suboptimal control regimen Apr 10, 2024
Immunotherapy After Definitive Therapy Flops in Head and Neck Cancer No event-free survival benefit with atezolizumab versus placebo in phase III trial Apr 10, 2024
Biden Admin Imposes National Limits on 'Forever Chemicals' in Drinking Water Most important action the EPA has ever taken on PFAS, says agency administrator Apr 10, 2024
Cancer Warnings on Booze; Rats, Roaches in Hospitals; Barefoot Pharma Workers Health news and commentary from around the Web gathered by 51˶ staff Apr 10, 2024
Accelerated Aging Linked to Recent Increase in Early-Onset Solid Tumors Strength of association increased in more recent birth cohorts Apr 09, 2024
Novel PARP1 Inhibitor Shows Promise in Breast Cancer The drug had favorable safety compared with first-generation PARP inhibitors in phase I/II study Apr 09, 2024
Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials? Study shows it may be an alternative to cancer-specific mortality for some cancers, but not all Apr 08, 2024
Most Cancer Drugs Granted Accelerated Approval Fail Confirmatory Trials Only 43% showed clinical benefit within 5 years Apr 08, 2024
Enhertu Gets Tumor-Agnostic FDA Approval for HER2-Positive Cancers About half of patients responded, duration of response as long as 19 months in three trials Apr 05, 2024
Cancer 'Tidal Wave' Forecast; Not Decaf, Too! Cautionary Tales of Cancer, Cannabis News, features, and commentary about cancer-related issues Apr 05, 2024
Incorporating Bereavement Into the Continuum of Care "Poor cousin of palliative care" needs more resources, buy-in, and normalization Apr 04, 2024
Chemotherapy/ICI Combos Falter as Second-Line Treatment for Gastric Cancer FOLFIRI plus durvalumab, with or without tremelimumab, no help after first-line chemotherapy Apr 04, 2024
Patient Stabs ED Worker; Campus Building Tied to Cancer; Your Gut and Heart Disease Health news and commentary from around the Web gathered by 51˶ staff Apr 03, 2024
Microwave Ablation a Safer Option for Multifocal Papillary Thyroid Carcinoma? Observational study suggests promising benefits of skipping surgery Apr 02, 2024
Some Cancer Patients Can Find It Hard to Tell Family and Friends Recent high-profile examples highlight this reluctance Mar 31, 2024
The Cancer Journey Is Not Unique to the Royals The U.S. needs a more human-centric care approach for all patients Mar 29, 2024
Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendations News, features, and commentary about cancer-related issues Mar 29, 2024
Oncologists Express Conflicted Views About AI in Clinical Practice Uncertainty about how the technology may fit with practice standards, medico-legal environment Mar 28, 2024
CDC: Latest COVID Vax Cuts Hospitalization Risk in Immunocompromised People But fewer than one in five of this vulnerable group have received the updated shot Mar 28, 2024
Death Is Inevitable. Doctors Should Be Prepared to Manage It Appropriately. End-of-life communication is a skill that must be practiced and honed Mar 28, 2024
Kate Middleton's Cancer: What to Know About 'Preventative' Chemotherapy And what abdominal surgery could mean in the context of cancer Mar 26, 2024
Reconsider Insertion of Abdominal Drains After Distal Pancreatectomy, Study Suggests Rate of major morbidity was non-inferior in the no-drain group compared with the drain group Mar 25, 2024
Graphic Images on Cigarettes of Smoking's Harm Are Constitutional, Court Rules Partial victory for federal regulators seeking to toughen warning labels Mar 22, 2024
Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancer News, features, and commentary about cancer-related issues Mar 22, 2024
No OS Difference in Pancreatic Cancer With SABR vs Irreversible Electroporation PFS, adverse events also comparable with the ablative modalities after FOLFIRINOX chemotherapy Mar 21, 2024
